Treatment | DNA content in tissues of | RNA content in tissues of | ||||
---|---|---|---|---|---|---|
Liver | Kidney | Brain | Liver | Kidney | Brain | |
Normal control | 0.66 ± 0.01a | 0.47 ± 0.02a | 0.51 ± 0.00a | 0.41 ± 0.0a | 0.31 ± 0.0a | 0.35 ± 0.0a |
Control oil treatment | 0.67 ± 0.01a | 0.46 ± 0.01a | 0.51 ± 0.01a | 0.41 ± 0.01a | 0.32 ± 0.01a | 0.36 ± 0.0a |
Bisphenol A (BPA) | 0.28 ± 0.00f | 0.21 ± 0.01g | 0.23 ± 0.01g | 0.22 ± 0.0g | 0.16 ± 0.01f | 0.15 ± 0.01f |
Protective low dose of FCE | 0.50 ± 0.01c | 0.39 ± 0.01cd | 0.40 ± 0.00c | 0.32 ± 0.0d | 0.26 ± 0.01c | 0.25 ± 0.0c |
Protective medium dose of FCE | 0.56 ± 0.00b | 0.40 ± 0.01bc | 0.46 ± 0.01b | 0.35 ± 0.0c | 0.27 ± 0.0b | 0.28 ± 0.0b |
Protective high dose of FCE | 0.59 ± 0.01b | 0.42 ± 0.01b | 0.48 ± 0.01b | 0.38 ± 0.0b | 0.29 ± 0.01b | 0.29 ± 0.0b |
Therapeutic low dose of FCE | 0.41 ± 0.00e | 0.33 ± 0.0f | 0.32 ± 0.0f | 0.27 ± 0.0f | 0.20 ± 0.0e | 0.20v0.01e |
Therapeutic medium dose of FCE | 0.44 ± 0.00d | 0.35 ± 0.0ef | 0.35 ± 0.0c | 0.28 ± 0.0ef | 0.21 ± 0.0e | 0.22 ± 0.1cd |
Therapeutic high dose of FCE | 0.47 ± 0.00d | 0.37 ± 0.01de | 0.38 ± 0.0d | 0.30 ± 0.0e | 0.23 ± 0.01d | 0.23 ± 0.0cd |